Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on DEINOVE. We currently have 6 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
03 Oct 16
While the H116 financial results were in line with expectations, the decision to suspend the Deinol programme was not. Short-term projections will not be affected by the change in strategy as resources will simply be reallocated, but potential for longer-term revenue generation will switch from biofuels to green chemistry and healthcare.
Commercial revenues expected 2018
10 Jun 16
Management believes that Deinove now has the necessary financial resources to continue with its work until the end of FY17 without recourse to further equity funding. Deinove will continue to progress towards commercialising its technology in both the Deinochem and Deinol projects, with first commercial revenues expected by 2018. Based on the assumption that it can successfully deploy its technology, we believe Deinove could be worth c €8/share (previously €10).
Finance secure until end 2017
30 Mar 16
Deinove made significant scientific and technical advances in 2015, signed important commercial agreements and improved the financial positioning of the company. The first commercial revenues are expected in 2018 and the company believes it has sufficient financial resources, without further equity drawdowns (€10m unused facility), to last it until the end of 2017.
Broadening the offering
12 Jan 16
Deinove has secured additional financial resources that will allow it to continue the development of its technology in the field of green chemistry and biofuels. The majority of the funds raised will be used to finance developments in Deinochem (green chemistry), which we now expect will contribute an increased proportion of future revenues.
Funding the road to commercial deployment
08 Dec 15
Deinove’s proposed capital raising (€9.3m) should allow the company to continue to develop its technology to the point when commercial revenues are expected to begin (2017/18). The intended distribution of the proceeds among Deinove’s businesses highlights the increased importance of the Deinochem offering within Deinove’s portfolio. It also highlights the greater number of potential revenue-generating projects beyond biofuels to which Deinove can now point.
Milestone payments demonstrate progress
25 Sep 15
Deinove continues to make progress, passing research project milestones, signing agreements with commercial partners and diversifying future potential revenue streams by broadening its research platform. The company has yet to generate commercial revenue (we expect from FY17), but believes it has sufficient cash resources to last “beyond Q316”.
GMP FirstEnergy ― UK Energy morning research package
06 Dec 16
Transglobe Energy (TGL CN); BUY, C$5.25: Homeward bound… back to Canada | Great Eastern Energy Corporation (GEEC LN) (not covered): Reserves update in India | BP (BP LN) (not covered): Acquiring interest in Tangguh in Indonesia | Exillon Energy (EXI LN) (not covered): Production update in Russia | Genel Energy (GENL LN); SPECULATIVE BUY, £2.60: Receipt of payment for Taq Taq export in Kurdistan | ExxonMobil (XOM US) (not covered): Relinquishing blocks in Kurdistan
16 Jan 17
We take a look at the rankings of the various countries in Africa that have a significant exposure to mining. We take the Transparency International corruption rankings as our starting point and modify these for exceptional geology and for current UK government travel warnings. Ghana, Botswana and Namibia come out as our top three, with Eritrea, Kenya and Zimbabwe at the bottom of our rankings.
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
19 Jan 17
Aggregated Micro Power* (AMPH): Funding for first peaking power plant project (CORP) | The Mission Marketing Group* (TMMG): Positive trading update (CORP) | Cello (CLL): Increasingly backed by, and leveraging, technology (BUY) | 4imprint (FOUR): Growth backed by strong cash flow continues (BUY) | Allergy Therapeutics (AGY): Positive trading update and market share gains drive upgrades (BUY) | Shanta Gold (SHG): Q4 operating results (BUY) | Sound Energy (SOU): Tendrara extended well test result (BUY) | Revolution Bars (RBG): Price target increase (BUY)
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.